Amira Pharmaceuticals Inc.


in
Amira Pharmaceuticals Inc. announced the hiring of Michael V. Swanson as the company's Chief Financial Officer. Swanson has over 30 years of experience in finance and accounting, including 17 years of CFO-level experience in life sciences and specialty pharmaceutical companies. Prior to joining Amira, Swanson was the CFO of Prometheus Laboratories Inc. During his time at Prometheus, Swanson led several financings totaling over $200 million dollars and, most recently, led the filing of a registration statement for Prometheus' initial public offering. Prior to Prometheus, Swanson was the CFO of Advanced Tissue Sciences Inc. where his responsibilities included the financing of this publicly-held, life sciences company.